Driving performance under maintenance treatment with buprenorphine;Substitution mit buprenorphin und fahrtauglichkeit-ergebnisse einer experimentellen untersuchung

Suchtmedizin in Forschung und Praxis

Volumn 4, Issue 1, 2002, Pages 17-24

  Kagerer, Sabine ^a   Backmund, Markus ^a   Walcher, Stefan ^a   Soyka, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Buprenorphine; Driving performance; Maintenance treatment; Opioid dependence; Psychomotor performance

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; ATTENTION; DRIVING ABILITY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; OPIATE ADDICTION; PSYCHOMOTOR ACTIVITY; PSYCHOPHARMACOLOGY; SCORING SYSTEM; VISION;

EID: 0036227418     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Alternate-day dosing during buprenorphine treatment of opioid dependence
2. Substitution mit buprenorphin bei HIV-positiven patienten: Wechselwirkungen mit proteaseinhibitoren?
3. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence
4. Comparison of methadone and high dosage buprenorphine users in French care centres
5. Buprenorphin in der detoxifikation; erste erfahrungen in psychiatrischen alltag
6. Buprenorphine treatment of opioid dependence: A review
7. Buprenorphine: Dose-related blockade of opioid challenge effects in opioid depended humans
8. A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
9. Buprenorphine dosing every 1,2, or 3 days in opioid-dependent patients
10. Use of buprenorphine in HIV-infected injection drug users: Negligible impact on virologic response to HAART
11. Understanding the opioid analgesics and their effects on skills performance
12. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids
13. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
14. Verlaufskontrolle bei opiatabhängigen Patienten, die ausgehend von Gesundheitsversorgungsnetzen mit hochdosiertem Buprenorphin behandelt werden
15. A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opiod dependence
16. Methadonsubstitution und fahrtauglichkeit
17. A possible role of opioids in depression: Significant improvement after buprenorphine
18. Possible antidepressive effects on opioids: Action of Buprenorphine
19. Treatment of opioid-dependent pregnant women with buprenorphine
20. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal
21. Limits to buprenorphine dosing: A comparison between quintuple and sextuple the maintenance dose every 5 days
22. Buprenorphin - Ein neuer Ansatz in der Pharmakotherapie opiatabhängiger Patienten
23. Mortality in heroin addiction impact of methadone treatment
24. Buprenorphin-Substitution in der Schwangerschaft: Geringeres Risiko neonataler Abstinenzsyndrome
25. Erste Erfahrungen mit Buprenorphin in der Methadonschwerpunktpraxis Mannheim
26. Electroconvulsive shock (ECS) results in a functional activation of endorphin systems
27. New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment
28. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction
29. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
30. Buprenorphine treatment of opioid dependence: Clinical trial of daily versus alternate-day dosing
31. A controlled trial of buprenorphine treatment for opiod dependence
32. Agonists, partial agonists, antagonists, inverse agonists and agonists/antagonists
33. Biological correlates of methadone maintenance pharmacotherapy
34. Buprenorphine versus methadone maintenace for opioid dependence
35. Buprenorphine is a potent κ-opioid receptor antagonist in pigeons and mice
36. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine
37. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial
38. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence
39. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
40. Three methods of opioid detoxification in a primary care setting
41. Buprenorphin und Carbamazepin in der Entgiftungs-behandlung von Opiatabhängigen mit Drogenbeigebrauch
42. Detoxifikation polytoxikomaner patienten mit buprenorphin
43. Buprenorphin: Aspekte der Therapie von Opiatabhängigkeit, Depression und Schizophrenie
44. Buprenorphine: A controlled clinical trial in the treatment of opiod dependence
45. A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence
46. Opiaterhaltungstherapie bei graviden drogenabhängigen Frauen und ihre Auswirkungen auf die Neugeborenen
47. Use of buprenorphine during pregnancy
48. Methadon-substituiton and driving ability
49. Antipsychotic effect of buprenorphine in schizophrenia
50. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse
51. The influence of prolongeed stable methadone maintenance treatment on mortality and employment: An 8-year follow-up
52. Methadone in the treatment of opioid dependence: A review of the world literature
53. Less driving impairment on buprenorphine than methadone in drug dependent patients?
54. Comparison of buprenorphine and methadone in the treatment of opioid dependence
55. Clinical pharmacology of buprenorphine: Ceiling effects at high doses